Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shreya Ramakrishnan
Observed name:
S Ramakrishnan
Institution:
The University of Western Australia
Observed institutions:
Edith Cowan University,
The University of Western Australia,
King's College London,
University of Oxford,
NIHR Oxford Biomedical Research Centre,
Institute for Respiratory Health,
Academy of Scientific and Innovative Research
show all 7
ORCID:
0009-0000-1178-7775
Observed ORCID:
0009-0000-1178-7775
OpenAlex ID:
A5032553404
Results reporting for clinical trials led by medical universities and university hospitals in the nordic countries was often missing or delayed
2025
·
Gustav Nilsonne
, Susanne Wieschowski
, et al.
·
Journal of Clinical Epidemiology
·
12
P270 Treatment failure at 1 year following benralizumab during an eosinophilic exacerbation: data from ABRA
2026
·
N Smallcombe
, E Dogu
, et al.
·
Thorax
PDF
P71 A global clinician survey of OCS stewardship in asthma exacerbations: time for T2-guided treatment?
2026
·
DL Sykes
, S Couillard
, et al.
·
Thorax
S175 Tracking eosinophils following prednisolone or benralizumab at the time of an exacerbation in the ABRA trial
2025
·
N Smallcombe
, M Zheng
, et al.
·
Thorax
M16 Treatment failures during an eosinophilic exacerbation following treatment with benralizumab or prednisolone: data from ABRA
2025
·
N Smallcombe
, M Zheng
, et al.
·
Thorax
P157 Effect of benralizumab on airway function measured by impulse oscillometry during eosinophilic exacerbations: results from the ABRA study
2025
·
A Lino-Alvarado
, M Zheng
, et al.
·
Thorax
PDF
S109 Treating eosinophilic exacerbations of asthma and COPD with benralizumab: a double blind, double dummy, active-placebo controlled randomised trial (ABRA)
2024
·
S Ramakrishnan
, REK Russell
, et al.
·
Thorax
P181 Bactericidal/ permeability-increasing protein is present in plasma of stable and exacerbating COPD patients
2024
·
YY Wong
, SP Cass
, et al.
·
Thorax
Regulatory gaps and research waste in clinical trials involving women with metastatic breast cancer in Germany
2024
·
Till Bruckner
, Daniel Sanchez
, et al.
·
F1000Research
PROM and PREM preferences in COPD-patients
2022
·
I Gyselinck
, K Vermeersch
, et al.
·
European Respiratory Journal
Show more works
View as search
Works count:
10
Citation count:
12
H-index:
1
I10-index:
1
Year
Topic
Type